346 related articles for article (PubMed ID: 27646604)
1. The Mucus Barrier to Inhaled Gene Therapy.
Duncan GA; Jung J; Hanes J; Suk JS
Mol Ther; 2016 Dec; 24(12):2043-2053. PubMed ID: 27646604
[TBL] [Abstract][Full Text] [Related]
2. Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.
Hida K; Lai SK; Suk JS; Won SY; Boyle MP; Hanes J
PLoS One; 2011; 6(5):e19919. PubMed ID: 21637751
[TBL] [Abstract][Full Text] [Related]
3. Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier.
Di Gioia S; Trapani A; Castellani S; Carbone A; Belgiovine G; Craparo EF; Puglisi G; Cavallaro G; Trapani G; Conese M
Pulm Pharmacol Ther; 2015 Oct; 34():8-24. PubMed ID: 26192479
[TBL] [Abstract][Full Text] [Related]
4. Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
Kim N; Kwak G; Rodriguez J; Livraghi-Butrico A; Zuo X; Simon V; Han E; Shenoy SK; Pandey N; Mazur M; Birket SE; Kim A; Rowe SM; Boucher R; Hanes J; Suk JS
Thorax; 2022 Aug; 77(8):812-820. PubMed ID: 34697091
[TBL] [Abstract][Full Text] [Related]
5. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.
Broughton-Head VJ; Smith JR; Shur J; Shute JK
Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310
[TBL] [Abstract][Full Text] [Related]
6. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic aerosols and airway secretions.
Rubin BK
J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
[TBL] [Abstract][Full Text] [Related]
8. An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy.
Duncan GA; Kim N; Colon-Cortes Y; Rodriguez J; Mazur M; Birket SE; Rowe SM; West NE; Livraghi-Butrico A; Boucher RC; Hanes J; Aslanidi G; Suk JS
Mol Ther Methods Clin Dev; 2018 Jun; 9():296-304. PubMed ID: 30038933
[TBL] [Abstract][Full Text] [Related]
9. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.
Kitson C; Angel B; Judd D; Rothery S; Severs NJ; Dewar A; Huang L; Wadsworth SC; Cheng SH; Geddes DM; Alton EW
Gene Ther; 1999 Apr; 6(4):534-46. PubMed ID: 10476213
[TBL] [Abstract][Full Text] [Related]
10. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.
Schuster BS; Kim AJ; Kays JC; Kanzawa MM; Guggino WB; Boyle MP; Rowe SM; Muzyczka N; Suk JS; Hanes J
Mol Ther; 2014 Aug; 22(8):1484-1493. PubMed ID: 24869933
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
Conte G; Costabile G; Baldassi D; Rondelli V; Bassi R; Colombo D; Linardos G; Fiscarelli EV; Sorrentino R; Miro A; Quaglia F; Brocca P; d'Angelo I; Merkel OM; Ungaro F
ACS Appl Mater Interfaces; 2022 Feb; 14(6):7565-7578. PubMed ID: 35107987
[TBL] [Abstract][Full Text] [Related]
13. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
[TBL] [Abstract][Full Text] [Related]
14. Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.
Leal J; Peng X; Liu X; Arasappan D; Wylie DC; Schwartz SH; Fullmer JJ; McWilliams BC; Smyth HDC; Ghosh D
J Control Release; 2020 Jun; 322():457-469. PubMed ID: 32243979
[TBL] [Abstract][Full Text] [Related]
15. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
[TBL] [Abstract][Full Text] [Related]
16. Extracellular barriers in respiratory gene therapy.
Sanders N; Rudolph C; Braeckmans K; De Smedt SC; Demeester J
Adv Drug Deliv Rev; 2009 Feb; 61(2):115-27. PubMed ID: 19146894
[TBL] [Abstract][Full Text] [Related]
17. Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.
Chen D; Liu J; Wu J; Suk JS
Expert Opin Drug Deliv; 2021 May; 18(5):595-606. PubMed ID: 33218265
[No Abstract] [Full Text] [Related]
18. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.
Mastorakos P; da Silva AL; Chisholm J; Song E; Choi WK; Boyle MP; Morales MM; Hanes J; Suk JS
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8720-5. PubMed ID: 26124127
[TBL] [Abstract][Full Text] [Related]
19. Mucus structure and properties in cystic fibrosis.
Rubin BK
Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle diffusion in respiratory mucus from humans without lung disease.
Schuster BS; Suk JS; Woodworth GF; Hanes J
Biomaterials; 2013 Apr; 34(13):3439-46. PubMed ID: 23384790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
